3 mg/day, but they cannot distinguish between increased absorption and decreased biliary excretion as the cause. After oral or intravenous administration of "4CU or 67Cu there is less radioisotope present in the stools of Wilson's disease patients than in control subjects (Bush, Mahoney, Markowitz, Gubler, Cartwright, and Wintrobe, 1955; Tauxe, Goldstein, Gross, and Randall, 1968a; Tauxe, Goldstein, Randall, and Gross, 1968b; O'Reilly, Weber, Oswald, and Shipley, 1971; Strickland, Beckner, Leu, and O'Reilly, 1972) , which could be due to a diminished excretion of radiocopper into bile by the liver in Wilson's disease. This explanation is supported by the demonstration, using external probe counting, of an apparent inability of the liver to discharge ff4Cu or 67CU (Tauxe et al, 1968a) , and also by the finding of a diminished concentration of radiocopper in the duodenal bile of patients with Wilson's disease (O'Reilly et al, 1971) . However, all these results are explicable on the basis of the radioisotope entering a much enlarged pool of copper in the liver (Sass-Kortsak, 1965; Scheinberg and Sternlieb, 1965) and therefore a much smaller proportion being excreted into bile. It is evident that these studies do not give unequivocal evidence that the absolute quantity of copper excreted into bile by the liver in Wilson's disease is diminished.
Studies on the concentration of copper in bile in normal subjects (Van Ravesteyn, 1944 ) and in patients with Wilson's disease (Denny-Brown and 125 Porter, 1951; Bickel et al, 1957; Cartwright and Wintrobe, 1964) (Go, Hofmann, and Summerskill, 1970; Ertan, Brooks, Ostrow, Arvan, Williams, and Cerda, 1971 
Materials and Methods
Biliary copper excretion rates were measured by the technique of Go et al (1970) , modified by the omission of gastric perfusion. All patients on penicillamine therapy stopped taking the drug at least 48 hours before the study. After an overnight fast, a multilumen tube was passed into the duodenum under radiographic control. Holes in the tube at the level of the second part of the duodenum enabled solutions to be perfused into the duodenum, while the aspiration holes were located at the duodenojejunal junction. A solution of 154 mM NaCI was infused for an initial equilibration period of 20 minutes, followed by a solution containing essential amino acids (Aminosol, Vitrum) very similar in concentration to that used by Go et al (1970) . This was infused for between two and three hours, and the infusion rate was 5 ml/min. The duodenum was aspirated continually, the collections being divided into 20-minute periods. Both the NaCl and amino acid solutions had no detectable copper and contained similar concentrations of the non-absorbed marker, 51CrC13 (0 5-2 0 ,uCi/100 ml).
The concentrations of 61CrC13 in the aspirates and the perfusion solutions were measured in a well-type counter. Copper concentrations were estimated by acid digestion of samples, followed by extraction with zinc dibenzyldithiocarbamate. The excretion rates of copper into the duodenum were calculated from previously described equations (Go et al, 1970) .
The ability of intraduodenal amino acids to stimulate bile flow to a similar degree in the two groups of patients was tested by measuring bile acid concentrations in the duodenal aspirates by a modification of a method for serum bile acids (Murphy, Billing, and Baron, 1970) and then calculating excretion rates.
Results
The fraction of infused marker recovered in the duodenal aspirate varied from 4.6 ± 1.6% to 85.6 + 13.4% (SEM) (Go et al, 1970; Ertan et al, 1971) show that the use of sufficient collection periods and subjects enables reproducible results to be obtained. The higher level of biliary copper excretion during the first hour of duodenal amino-acid perfusion is attributable to continued gallbladder contraction.
The differences in the copper excretion rates found in the two groups could be due not only to differences in metabolism but also to inadequate stimulation of the liver to produce bile by the amino-acid solution in cases of Wilson's disease, and/or differences in the degree of impairment of liver function. However, the similarity of bile acid excretion rates in the two groups of patients suggests that bile flow was not significantly depressed in the Wilson's disease patients. In addition, in neither group was impaired liver function associated with a significantly diminished biliary copper excretion rate (table II) . Both in patients with liver dysfunction and in those without, the copper excretion rates were significantly lower in those with Wilson's disease.
It is very unlikely that the differences found between the two groups of subjects in the rates of copper excreted into the duodenum are due, in fact, to differences in the rates of absorption of biliary copper in the perfused segment of duodenum. In man the main site of absorption of copper appears to be in the stomach rather than the duodenum (Weber, O'Reilly, Pollycove, and Shipley, 1969) , and the shortness of the segment perfused (approximately 11.5 cm) would have resulted in a rapid transit of duodenal contents. Studies in vitro on the bile of patients with and without Wilson's disease (Frommer, 1971 ) have indicated that the strength and manner of binding of copper in the two groups of subjects are the same. This contradicts the suggestion that there is increased absorption of biliary copper because it is in a non-bound diffusible form in Wilson's disease (Mistilis and Farrer, 1968 is within the range of 500 to 1300,ug/day for normal subjects calculated by Cartwright and Wintrobe (1964) . Normal adults must be in copper balance, since the copper content of the body is maintained within a fairly narrow range irrespective of age (Sass-Kortsak, 1965) , and the majority of copper balance studies have confirmed this. Therefore, since normally urinary copper excretion is negligible gastrointestinal (mainly biliary) copper excretion must be equal to gastrointestinal copper absorption.
If Wilson's disease patients absorb the same amount of copper as normal subjects (viz, 1210 ,ug/day), a biliary copper excretion of 590 ,ug/day would result in a diet-stool difference of 620 Kg/day. This is close to the figure of 676 ,ug/day for the mean diet-stool difference in Wilson's disease which I have calculated from the data in the literature (Cartwright et al, 1954; Bickel et al, 1957; Playoust and Dale, 1961; Sunderman et al, 1963; Goldstein et al, 1965; Canelas et al, 1967; Strickland et al, 1971 . However, the increased copper excretion in urine in the later stages of the disease will substantially reduce the net positive copper balance. The finding of diminished biliary copper excretion in Wilson's disease enables a more satisfactory explanation to be given for the accumulation of copper than that of Uzman, Iber, Chalmers, and Knowlton (1956) , or of postulating that there is increased copper absorption due either to diminished serum caeruloplasmin levels (Scheinberg and Stemlieb, 1960) or to abnormalities of bile acid metabolism (Lewis, 1973) . Since the rate of uptake of copper by the liver in the early stages of the disease is close to normal (Tauxe et al, 1968a) , the inability of the hepatocyte to secrete copper into bile or caeruloplasmin into blood could be explained by a block in the intrahepatic handling of copper. Such a block may be due to a deficiency or abnormality in an enzyme involved in the transport of copper from the site of uptake by the hepatocyte or from storage within lysosomes (Sternlieb, Van den Hamer, Morell, Alpert, Gregoriades, and Scheinberg, 1973) . As serum concentrations of apocaeruloplasmin have been reported to be near normal in patients with Wilson's disease (Carrico, Deutsch, Beinert, and Orme-Johnson, 1969; Matsuda and Holtzman, 1973) , the defective caeruloplasmin production is probably related to the diminished binding of copper to its apoprotein. Further elucidation of the basic defect of Wilson's disease must await a more detailed study of copper metabolism within the liver cell.
"5Zr, a whole-body counter and the scintillation camera. J. 
